Skip to Main Content

Author Details

Xin Wei Wang
Center for Cancer Research, National Cancer Institute (NCI)
1994
188
77
PMIDPaper TitleJournal TitlePublished Year
36593103MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression.Gut2023
37747420Targeting WNT/β-Catenin via Modulating EZH2 Function: A New Chapter in the Treatment of β-Catenin Mutant Hepatocellular Carcinoma?Cancer Res2023
37595566Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin.Cell2023
37906280Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiency.JCI Insight2023
37094826Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma through m 6 A-mediated epitranscriptomic regulation.Hepatology2023
36593103MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression.Gut2023
36906109MYC determines lineage commitment in KRAS-driven primary liver cancer development.J Hepatol2023
37338984Monocyte-derived macrophages orchestrate multiple cell-type interactions to repair necrotic liver lesions in disease models.J Clin Invest2023
37452065Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma.Sci Rep2023
36697706Immunology and immunotherapy of cholangiocarcinoma.Nat Rev Gastroenterol Hepatol2023
36797475Stiff matrix induces exosome secretion to promote tumour growth.Nat Cell Biol2023
37224815Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy.Cell Rep Med2023
36598996The repertoire of CSF antiviral antibodies in patients with neuroinflammatory diseases.Sci Adv2023
37595566Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin.Cell2023
37906280Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiency.JCI Insight2023
37747420Targeting WNT/β-Catenin via Modulating EZH2 Function: A New Chapter in the Treatment of β-Catenin Mutant Hepatocellular Carcinoma?Cancer Res2023
37452065Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma.Sci Rep2023
37338984Monocyte-derived macrophages orchestrate multiple cell-type interactions to repair necrotic liver lesions in disease models.J Clin Invest2023
37094826Purine anabolism creates therapeutic vulnerability in hepatocellular carcinoma through m 6 A-mediated epitranscriptomic regulation.Hepatology2023
37224815Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy.Cell Rep Med2023
36697706Immunology and immunotherapy of cholangiocarcinoma.Nat Rev Gastroenterol Hepatol2023
36906109MYC determines lineage commitment in KRAS-driven primary liver cancer development.J Hepatol2023
36797475Stiff matrix induces exosome secretion to promote tumour growth.Nat Cell Biol2023
36598996The repertoire of CSF antiviral antibodies in patients with neuroinflammatory diseases.Sci Adv2023
34340996The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma.Gut2022
35838048Creatine riboside is a cancer cell-derived metabolite associated with arginine auxotrophy.J Clin Invest2022
35961709Causes and functional intricacies of inter- and intratumor heterogeneity of primary liver cancers.Adv Cancer Res2022
35378172Metformin treatment rescues CD8<sup>+</sup> T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD.J Hepatol2022
36274950A compendium of co-regulated mitoribosomal proteins in pan-cancer uncovers collateral defective events in tumor malignancy.iScience2022
36263161Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2.Int J Biol Sci2022
35723626IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma.Cancer Discov2022
36512331Dissecting intratumor heterogeneity in HCC: new research strategies and clinical implications.Carcinogenesis2022
36476645Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer.Nat Commun2022
34340996The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma.Gut2022
35331674The gut-liver axis: host microbiota interactions shape hepatocarcinogenesis.Trends Cancer2022
35274717A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma.Oncologist2022
35034369Single-cell biology uncovers apoptotic cell death and its spatial organization as a potential modifier of tumor diversity in HCC.Hepatology2022
35838048Creatine riboside is a cancer cell-derived metabolite associated with arginine auxotrophy.J Clin Invest2022
35378172Metformin treatment rescues CD8<sup>+</sup> T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD.J Hepatol2022
35723626IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma.Cancer Discov2022
36476645Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer.Nat Commun2022
36512331Dissecting intratumor heterogeneity in HCC: new research strategies and clinical implications.Carcinogenesis2022
36274950A compendium of co-regulated mitoribosomal proteins in pan-cancer uncovers collateral defective events in tumor malignancy.iScience2022
35961709Causes and functional intricacies of inter- and intratumor heterogeneity of primary liver cancers.Adv Cancer Res2022
36263161Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2.Int J Biol Sci2022
35034369Single-cell biology uncovers apoptotic cell death and its spatial organization as a potential modifier of tumor diversity in HCC.Hepatology2022
35274717A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma.Oncologist2022
35331674The gut-liver axis: host microbiota interactions shape hepatocarcinogenesis.Trends Cancer2022
31379005NMR characterization of rearranged staurosporine aglycone analogues from the marine sponge Damiria sp.Magn Reson Chem2021
34130336Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution.Semin Liver Dis2021
  • 1 - 50 of 376

Recommended Authors

Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 1
Runze Shang
Affiliated Haixia Hospital of Huaqiao University (The Hospital)
Career Start Year 2014
Number of shared co-authors 1
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 3
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 2
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 0
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 9
Aparna Jayachandran
The University of Queensland
Career Start Year 2007
Number of shared co-authors 0
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 3
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 2
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 2
Silvano Piazza
International Centre for Genetic Engineering and Biotechnology
Career Start Year 2004
Number of shared co-authors 1
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Bin Yan
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 2
Li Liu
Nanfang Hospital, Southern Medical University
Career Start Year 2003
Number of shared co-authors 0
Emiliano Dalla
University of Udine
Career Start Year 2002
Number of shared co-authors 1
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Arndt Vogel
Clinic for Gastroenterology, Medical University Hannover
Career Start Year 2001
Number of shared co-authors 5
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 3
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 5
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 2
Hidewaki Nakagawa
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 4
Phillip Buckhaults
University of South Carolina
Career Start Year 1993
Number of shared co-authors 0
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 4
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 4
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 0
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 4
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 1
Hoguen Kim
Korea Advanced Institute of Science and Technology (KAIST)
Career Start Year 1982
Number of shared co-authors 1

Collaborators

Tim F Greten
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 21
Hien Dang
Co-authored papers 20
Snorri S Thorgeirsson
Co-authored papers 16
Stephanie Roessler
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 16
Mathuros Ruchirawat
Chulabhorn Research Institute
Co-authored papers 11
Yotsawat Pomyen
Co-authored papers 7
Ana I Robles
Co-authored papers 7
Chi Ma
Affiliated Yantai Yuhuangding Hospital of Qingdao University
Co-authored papers 7
Yidong Chen
Zhujiang Hospital, Southern Medical University
Co-authored papers 7
Thomas Longerich
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 7
Bernd Heinrich
Clinic for Gastroenterology, Hannover Medical School
Co-authored papers 6
Xiaolin Wu
Leidos Biomedical Research Inc.
Co-authored papers 6
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 6
Eytan Ruppin
National Cancer Institute
Co-authored papers 6
Firouzeh Korangy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 6
Lars Zender
Co-authored papers 6
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Valerie Fako
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Giorgio Trinchieri
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Alexander Kroemer
Co-authored papers 3
Wen Xue
Co-authored papers 3
Qianfei Zhang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Qimin Zhan
Peking University Cancer Hospital
Co-authored papers 2
Ettore Appella
Co-authored papers 2
Thomas Ried
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Bradford J Wood
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Albert J Fornace
Co-authored papers 2
Qiong Fu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Tatsuhiro Shibata
Kurume University School of Medicine
Co-authored papers 2
Release 1.2